Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132144) titled 'Chemotherapy combined with immunotherapy and targeted drugs, along with concurrent or sequential radiotherapy, for the treatment of locally advanced unresectable esophageal cancer: A retrospective comparative study on safety and efficacy' on Sept. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
locally advanced esophageal cancer
Intervention:
Chemotherapy, immunotherapy, targeted therapy in combination with radiotherapy group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026...